Trial intelligence / Profile preview

Rivastigmine augmentation in combat-related post-traumatic stress disorder

IRCT201211195280N10Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Aug 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of rivastigmine in post-traumatic stress disorder (PTSD), sponsored by Mashhad University of Medical Sciences. Started Aug 2009; status: completed.

02

Drugs

rivastigmine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on IRCT201211195280N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201211195280N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call